Viva Biotech Holdings (HKG:1873)
Hong Kong · Delayed Price · Currency is HKD 2.240
+0.150 (7.18%)
At close: Mar 6, 2026
Viva Biotech Holdings Market Cap
Viva Biotech Holdings has a market cap or net worth of 4.73 billion as of March 6, 2026. Its market cap has increased by 128.37% in one year.
Market Cap
4.73B
Enterprise Value
5.02B
Revenue
2.01B
Ranking
n/a
PE Ratio
32.76
Stock Price
2.24
Market Cap Chart
Since May 9, 2019, Viva Biotech Holdings's market cap has decreased from 6.63B to 4.73B, a decrease of -28.70%. That is a compound annual growth rate of -4.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.73B | 24.44% |
| Dec 31, 2025 | 3.80B | 109.02% |
| Dec 31, 2024 | 1.82B | -19.19% |
| Dec 29, 2023 | 2.25B | -32.91% |
| Dec 30, 2022 | 3.35B | -62.94% |
| Dec 31, 2021 | 9.04B | -48.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocumension Therapeutics | 5.46B |
| Laekna | 5.35B |
| Beijing Luzhu Biotechnology | 4.85B |
| Mirxes Holding Company | 4.49B |
| Shandong Boan Biotechnology | 4.40B |
| Jacobio Pharmaceuticals Group | 4.31B |
| TYK Medicines | 3.94B |
| AIM Vaccine | 3.64B |